用免疫血清、超免疫血清和链霉素治疗兔热病的比较研究。 - Suppr

Suppr

超能文献

A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin.

作者信息

FOSHAY L

出版信息

Am J Med. 1946 Aug;1:180-8. doi: 10.1016/0002-9343(46)90036-8.

DOI:10.1016/0002-9343(46)90036-8

PMID:20993803

Abstract

摘要

相似文献

A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin.

Am J Med. 1946 Aug;1:180-8. doi: 10.1016/0002-9343(46)90036-8.

Streptomycin studies in tularemia; streptomycin therapy in white rats.

J Infect Dis. 1949 Jul-Aug;85(1):39-44. doi: 10.1093/infdis/85.1.39.

Streptomycin studies in tularemia; streptomycin therapy in monkeys.

J Infect Dis. 1949 Jul-Aug;85(1):45-61. doi: 10.1093/infdis/85.1.45.

Treatment of tularemia with streptomycin.

Am J Med. 1947 May;2(5):467-73. doi: 10.1016/0002-9343(47)90092-2.

Streptomycin treatment of tularemia.

J Am Med Assoc. 1946 Feb 16;130:393-8. doi: 10.1001/jama.1946.02870070013004.

Streptomycin treatment in tularemia.

J Am Med Assoc. 1946 Sep 28;132:195-200. doi: 10.1001/jama.1946.02870390011003.

Streptomycin treatment of tularemia.

Am J Med. 1947 Jul;3(1):117. doi: 10.1016/0002-9343(47)90120-4.

Streptomycin in treatment of tularemia.

Trans Assoc Am Physicians. 1947;60(1 vol):181-6.

Tularemia; treatment of a case with streptomycin.

South Med J. 1946 Oct;39:774-7.

[Treatment of respiratory tularemia with streptomycin].

Klin Med (Mosk). 1953 Jun;31(6):47-50.

引用本文的文献

Clin Transl Immunology. 2021 Jan 19;10(1):e1239. doi: 10.1002/cti2.1239. eCollection 2021.

A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.

Clin Exp Immunol. 2019 Nov;198(2):143-152. doi: 10.1111/cei.13356. Epub 2019 Sep 12.

Tularemia vaccine development: paralysis or progress?

Vaccine (Auckl). 2016;6:9-23. doi: 10.2147/VDT.S85545. Epub 2016 May 4.

Host-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity.

Infect Drug Resist. 2014 Sep 18;7:239-51. doi: 10.2147/IDR.S53700. eCollection 2014.

Uncovering the components of the Francisella tularensis virulence stealth strategy.

Front Cell Infect Microbiol. 2014 Mar 7;4:32. doi: 10.3389/fcimb.2014.00032. eCollection 2014.

Immunotherapy for tularemia.

Virulence. 2013 Nov 15;4(8):859-70. doi: 10.4161/viru.25454. Epub 2013 Jun 19.

Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

PLoS One. 2012;7(3):e33349. doi: 10.1371/journal.pone.0033349. Epub 2012 Mar 12.

Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.

Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.

Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Clin Vaccine Immunol. 2009 Mar;16(3):414-22. doi: 10.1128/CVI.00362-08. Epub 2009 Jan 28.

Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody.

Vaccine. 2008 Dec 9;26(52):6874-82. doi: 10.1016/j.vaccine.2008.09.077. Epub 2008 Oct 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验